Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Keiko, ARAI"'
Autor:
Shinichiro Shirabe, Katsuya Yamazaki, Mariko Oishi, Keiko Arai, Noriharu Yagi, Manaka Sato, Masakazu Takeuchi, Takahito Kai, Hiroshi Maegawa
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 1, Pp 75-80 (2023)
ABSTRACT We assessed the prescription patterns of oral antidiabetic drugs in Japanese patients with type 2 diabetes between 2002 and 2020 using data from the Computerized Diabetes Care database. Among 172,960 patients treated with oral antidiabetic d
Externí odkaz:
https://doaj.org/article/4e2fc06ae4014fd685632191a3d4197a
Autor:
Noriharu Yagi, Ichiro Komiya, Keiko Arai, Mariko Oishi, Yoshihide Fukumoto, Shinichirou Shirabe, Hiroki Yokoyama, Katsuya Yamazaki, Hidekatsu Sugimoto, Hiroshi Maegawa, Japan Diabetes Clinical Data Management Study Group (JDDM study group),
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 1, Pp 65-73 (2022)
Abstract Aims/Introduction Type 2 diabetes mellitus is caused by a relative imbalance between insulin secretion and sensitivity related to the body mass index (BMI). Seven categories of oral antidiabetic drugs (OADs) are available in Japan. It is imp
Externí odkaz:
https://doaj.org/article/ec12e679327a4f17b385fb79e7b6b02b
Autor:
Shinichiro Shirabe, Katsuya Yamazaki, Mariko Oishi, Keiko Arai, Noriharu Yagi, Manaka Sato, Masakazu Takeuchi, Takahito Kai, Hiroshi Maegawa
Publikováno v:
Journal of Diabetes Investigation. 14:75-80
We assessed the prescription patterns of oral antidiabetic drugs in Japanese patients with type 2 diabetes between 2002 and 2020 using data from the Computerized Diabetes Care database. Among 172,960 patients treated with oral antidiabetic drugs, bot
Autor:
Naoko Teruya, Keiko Arai, Hideyasu Kohama, Yukihiro Shibuya, Yasushi Chuma, Kazuhiro Matsuo, Goro Matsuzaki
Publikováno v:
Immunopharmacology and Immunotoxicology. 43:203-211
Multiple sclerosis (MS) is an autoimmune disease mediated by a pro-inflammatory immune response. Experimental autoimmune encephalomyelitis (EAE) induced by immunization of mice with a myelin oligod...
Autor:
Keiko, Arai, Tetsuo, Nishikawa, Yoko, Matsuzawa, Shigeyuki, Ohtsu, Shin-Ichiro, Shirabe, Shohei, Yuasa, Koichi, Hirao, Hisao, Mori
Publikováno v:
Diabetes therapy : research, treatment and education of diabetes and related disorders. 13(2)
Periodontal disease is a common inflammation worldwide and is not only the foremost cause of tooth loss but also a cause of deterioration of glycemic control in patients with diabetes mellitus. In addition, effective glycemic management improves the
Autor:
Koich Hirao, Shohei Yuasa, Tetsuo Nishikawa, Keiko Arai, Shin-ichiro Shirabe, Hisao Mori, Yoko Matsuzawa, Shigeyuki Ohtsu
Publikováno v:
Diabetol Int
AIM: We aimed to investigate the certainty of using sulfonylureas in Japanese patients with type 2 diabetes mellitus (T2DM) by analyzing data from the 2018 Nationwide Survey on Actual Intervention for T2DM by Japanese Practitioners (NSAID Study). MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2852822d37db4f126d2f117b98ad6807
https://europepmc.org/articles/PMC8733091/
https://europepmc.org/articles/PMC8733091/
Autor:
Ayako Yoshimoto, Atsushi Kumakura, Yoko Koike, Yasuo Terauchi, Hajime Maeda, Koichi Hirao, Shin-ichiro Shirabe, Keiko Arai
Publikováno v:
Diabetes Research and Clinical Practice. 149:140-146
Aims Information on the clinical efficacy of SGLT2 inhibitors in the Japanese population is limited. The aim of this single-arm, single-center, open-label study was to confirm the body weight- and fat mass-lowering effects of canagliflozin (CANA) and
Autor:
Noriharu Yagi, Ichiro Komiya, Keiko Arai, Mariko Oishi, Yoshihide Fukumoto, Shinichirou Shirabe, Hiroki Yokoyama, Katsuya Yamazaki, Hidekatsu Sugimoto, Hiroshi Maegawa, Japan Diabetes Clinical Data Management Study Group (JDDM study group)
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 13, Iss 1, Pp 65-73 (2022)
Journal of Diabetes Investigation, Vol 13, Iss 1, Pp 65-73 (2022)
Aims/Introduction:Type 2 diabetes mellitus is caused by a relative imbalance between insulin secretion and sensitivity related to the body mass index (BMI). Seven categories of oral antidiabetic drugs (OADs) are available in Japan. It is important to
Autor:
Keiko Arai, Yukihiro Shibuya, Kazuhiro Matsuo, Yasushi Chuma, Goro Matsuzaki, Hideyasu Kiyohara, Naoko Teruya
Multiple sclerosis (MS) is an autoimmune disease mediated by myelin autoantigen-specific T cells. Experimental autoimmune encephalomyelitis (EAE) induced by immunization of mice with a myelin oligodendrocyte glycoprotein (MOG) peptide emulsified in k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::832f66f0457a1d9e709afc751562c16f
https://doi.org/10.22541/au.159818493.33207117
https://doi.org/10.22541/au.159818493.33207117